Story perspectives

Senate Democrats Blast Trump Over Drug Price Manipulation

2/6/2026

50 10

Summary

Story summary

Senator Ron Wyden (D-OR) leads Democrats criticizing U.S. President Donald Trump on drug prices.
Senators accuse Trump of letting Big Pharma delay negotiations and offer no commitments.
Wyden calls Trump’s actions a fraud, citing an $8.8 billion windfall for the pharmaceutical industry.
They plan policies using international pricing models and ending protections for high-priced drugs.
They aim to cut costs for American families and criticize the Trump administration's healthcare response.

1 of 1

Story summary

Senator Ron Wyden (D-OR) leads Democrats criticizing U.S. President Donald Trump on drug prices.
Senators accuse Trump of letting Big Pharma delay negotiations and offer no commitments.
Wyden calls Trump’s actions a fraud, citing an $8.8 billion windfall for the pharmaceutical industry.
They plan policies using international pricing models and ending protections for high-priced drugs.
They aim to cut costs for American families and criticize the Trump administration's healthcare response.